Kerman University of Medical Sciences International Journal of Health Policy and Management 2322-5939 10 4 2021 04 01 Evidence-Informed Deliberative Processes for HTA Around the Globe: Exploring the Next Frontiers of HTA and Best Practices; Comment on “Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe” 232 236 3881 10.34172/ijhpm.2020.145 EN Unni Gopinathan Division for Health Services, Norwegian Institute of Public Health, Oslo, Norway Trygve Ottersen Division for Health Services, Norwegian Institute of Public Health, Oslo, Norway Pascale-Renée Cyr Department of Community Medicine and Global Health, Institute of Health and Society, University of Oslo, Oslo, Norway Kalipso Chalkidou Global Health Development Group, Imperial College London School of Public Health, London, UK Center for Global Development Europe, London, UK Journal Article 2020 05 21 This comment reflects on an article by Oortwijn, Jansen, and Baltussen about the use and features of ‘evidence-informed deliberative processes’ (EDPs) among health technology assessment (HTA) agencies around the world and the need for more guidance. First, we highlight procedural aspects that are relevant across key steps of EDP, focusing on conflict of interest, the different roles of stakeholders throughout a HTA and public justification of decisions. Second, we discuss new knowledge and models needed to maximize the value of deliberative processes at the expanding frontiers of HTA, paying special attention to when HTA is applied in primary care, employed for public health interventions, and is produced through international collaboration. Health Technology Assessment Health Policy Deliberative Processes Decision-Making Priority Setting https://www.ijhpm.com/article_3881_be8c3bab042007be6c7f0a02f84a28cc.pdf